Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
In a nationwide sample of Black women in the U.S., we assessed preferences for HIV preexposure prophylaxis (PrEP) products, including long-acting injectable (LAI) PrEP and once-daily oral PrEP. Among 315 respondents, 32.1% were aware of PrEP and 40.6% were interested in using it; interest increased to 62.2% if PrEP were provided for free. Oral PrEP was the preferred option (51.1%), followed by LAI PrEP (25.7%), vaginal gel (16.5%), and vaginal ring (6.7%). When examining oral and LAI PrEP alone, most (62.7%) preferred oral PrEP. LAI PrEP was more likely to be preferred among respondents with concerns about healthcare costs or PrEP-related stigma, and among those who reported inconsistent condom use and multiple sexual partners. Although most Black women preferred oral PrEP, LAI PrEP may be appealing to a subset with social and structural barriers to PrEP use, such as cost and stigma, and those at increased risk of HIV infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
AIDS and behavior - 26(2022), 7 vom: 05. Juli, Seite 2212-2223 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Irie, Whitney C [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-HIV Agents |
---|
Anmerkungen: |
Date Completed 06.06.2022 Date Revised 12.09.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10461-021-03571-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33521004X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33521004X | ||
003 | DE-627 | ||
005 | 20231225225331.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10461-021-03571-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1117.xml |
035 | |a (DE-627)NLM33521004X | ||
035 | |a (NLM)34985607 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Irie, Whitney C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.06.2022 | ||
500 | |a Date Revised 12.09.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a In a nationwide sample of Black women in the U.S., we assessed preferences for HIV preexposure prophylaxis (PrEP) products, including long-acting injectable (LAI) PrEP and once-daily oral PrEP. Among 315 respondents, 32.1% were aware of PrEP and 40.6% were interested in using it; interest increased to 62.2% if PrEP were provided for free. Oral PrEP was the preferred option (51.1%), followed by LAI PrEP (25.7%), vaginal gel (16.5%), and vaginal ring (6.7%). When examining oral and LAI PrEP alone, most (62.7%) preferred oral PrEP. LAI PrEP was more likely to be preferred among respondents with concerns about healthcare costs or PrEP-related stigma, and among those who reported inconsistent condom use and multiple sexual partners. Although most Black women preferred oral PrEP, LAI PrEP may be appealing to a subset with social and structural barriers to PrEP use, such as cost and stigma, and those at increased risk of HIV infection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Black women | |
650 | 4 | |a Cabotegravir | |
650 | 4 | |a HIV prevention | |
650 | 4 | |a Long-acting injectable (LAI) | |
650 | 4 | |a Preexposure prophylaxis (PrEP) | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
700 | 1 | |a Calabrese, Sarah K |e verfasserin |4 aut | |
700 | 1 | |a Patel, Rupa R |e verfasserin |4 aut | |
700 | 1 | |a Mayer, Kenneth H |e verfasserin |4 aut | |
700 | 1 | |a Geng, Elvin H |e verfasserin |4 aut | |
700 | 1 | |a Marcus, Julia L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t AIDS and behavior |d 1997 |g 26(2022), 7 vom: 05. Juli, Seite 2212-2223 |w (DE-627)NLM09651440X |x 1573-3254 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2022 |g number:7 |g day:05 |g month:07 |g pages:2212-2223 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10461-021-03571-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2022 |e 7 |b 05 |c 07 |h 2212-2223 |